Item 2.02 Results of Operations and Financial Condition.
On November 8, 2021, AVEO Pharmaceuticals, Inc. (the "Company") issued a press
release announcing its financial results for the quarter ended September 30,
2021. The full text of the press release issued in connection with the
announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d)  Exhibits
99.1          Q    3     2021 earnings press release issued by the Company on     Nov    ember
            8    , 2021
104         Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses